Acta Med. 2003, 46: 183-188

https://doi.org/10.14712/18059694.2019.31

Platelets Activation in Patients Undergoing PTCA and Their Responsiveness After in vitro Stimulation

Martina Loudová, Jan Krejsek

Charles University in Prague, Faculty of Medicine in Hradec Králové, Department of Clinical Immunology and Allergology, Hradec Králové, Czech Republic

Received May 1, 2003
Accepted August 1, 2003

References

1. Abrams CH, Ellison N, Budzynski AZ et al. Direct detection of activated platelets and platelet – derived microparticles in humans. Blood 1990; 75(1): 128–38.
2. Abrams CH, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemostas 1991; 65(5):467–73.
3. Ault KA, Mitchell J. Analysis of platelets by flow cytometry. Methods in Cell Biology 1994; 42:275–94. <https://doi.org/10.1016/S0091-679X(08)61080-8>
4. Ault KA, Rinder HM, Mitchell JG et al. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989; 10:448–55. <https://doi.org/10.1002/cyto.990100413>
5. Cappani M, Prisco D, Antonucci E et al. The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty. Int J Clin Lab Res 1999; 29(4):145–9. <https://doi.org/10.1007/s005990050081>
6. Dehmer GJ, Nichols TC, Bode AP et al. Assessment of platelet activation by coronary sinus blood sampling during baloon angioplasty and directional coronary atherectomy. Am J Cardiol 1997; 80(7):871–7. <https://doi.org/10.1016/S0002-9149(97)00538-9>
7. Furman MI, Benoit MR, Barnard RM. Increased platelet reactivity and circulating monocyte-platelet aggregates in patient with stable coronary artery disease. J Am Coll Cardiol 1998; 31(2):352–8. <https://doi.org/10.1016/S0735-1097(97)00510-X>
8. Gasperetti CM, Gonias SL, Gimple LW et al. Platelet activation during coronary angioplasty in humans. Circulation 1993; 88:2728–33. <https://doi.org/10.1161/01.CIR.88.6.2728>
9. Gawaz MP, Mujais SK, Schmidt B et al. Platelet leukocyte aggregation during hemodialysis. Kidney Int 1994; 46:489–95. <https://doi.org/10.1038/ki.1994.299>
10. Gawaz M, Neumann FJ, Ott I et al. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996; 93:229–37. <https://doi.org/10.1161/01.CIR.93.2.229>
11. Gawaz M, Neumann FJ, Ott I et al. Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. Coron Artery Dis 1997; 8(3–4):121–8. <https://doi.org/10.1097/00019501-199703000-00001>
12. Holada K, Kružík P, Mikolajová M et al. The fluorescence flow cytometry technique in the diagnosis of hereditary platelet disorders—a case of Glanzmann’s thrombasthenia. Cas Lek Cesk 1994; 133(23):734–6.
13. Inoue T, Sohma R, Miyazaki T et al. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 2000; 86(10):1057–62. <https://doi.org/10.1016/S0002-9149(00)01159-0>
14. Itoh T, Nakai K, Ono M et al. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin? Coron Artery Dis 1995, 6(8):645–50. <https://doi.org/10.1097/00019501-199508000-00009>
15. Jakso P, Pajor L. Advantages of CD45 vs. side scatter based gating in the course of flow cytometric immuno-phenotyping in malignant hematologic diseases. Orv Hetil 1998; 139(42):2509–13.
16. Knight CHJ, Panesar M, Wilson DJ et al. Different effects of calcium antagonists, nitrates and β-blockers on platelet function. Possible importance for the treatment of unstable angina. Circulation 1997; 95:125–32. <https://doi.org/10.1161/01.CIR.95.1.125>
17. Koksch M. Durchflusszytometrische Diagnostik von Thrombozyten. Coulter – Immunotech Diagnostics. Manual. Leipzig.1997:18–26.
18. Kolarov P, Tschoepe D, Nieuwenhuis HK et al. PTCA: periprocedural platelet activation. Part II of Duesseldorf PTCA platelet study (DPPS). Eur Heart J 1996; 17(8):1216–22. <https://doi.org/10.1093/oxfordjournals.eurheartj.a015039>
19. Koza JM, Shankey TV, Walenga JM et al. Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudin. Invest Radiol 1995; 30(2):90–7. <https://doi.org/10.1097/00004424-199502000-00005>
20. Lefkowits J, Plow E, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 333(23):1553–9. <https://doi.org/10.1056/NEJM199506083322306>
21. Li N, Goodall AH, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leukocyte aggregates. Br J Haematol 1997; 99(4):808–16. <https://doi.org/10.1046/j.1365-2141.1997.4993305.x>
22. Li N, Goodall A, Hjemdahl P. Efficient flow cytometric assay for platelet – leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999; 35:154–61. <https://doi.org/10.1002/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y>
23. Matzdorff AC, Berchner D, Kuhnel G et al. Relative and absolute changes of activated platelets, microparticles anded platelets, microparticles andation in vitro. Haemostasis 1999; 28(6):277–88.
24. Matzdorff AC, Kühnel G, Kemkes-Matthes B et al. Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry. J Clin Med 1998; 131(6):507–17.
25. Michelson AD, Barnard MR, Krueger LA et al. Evaluation of platelet function by flow cytometry. Methods 2000; 21(3):259–70. <https://doi.org/10.1006/meth.2000.1006>
26. Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Haematol 1999, 6(5):342–48. <https://doi.org/10.1097/00062752-199909000-00012>
27. Murakami T, Komiyama Y, Masuda M et al. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur J Clin Invest 1996; 26: 996–1003. <https://doi.org/10.1046/j.1365-2362.1996.2360585.x>
28. Neumann FJ, Ott I, Gawaz M et al. Neutrophil and platelet activation at balooninjured coronary artery plaque in patients undergiong angioplasty. J Am Coll Cardiol 1996; 27(4):819–24. <https://doi.org/10.1016/0735-1097(95)00563-3>
29. Scharf RE, Tomer A., Marzec UM et al. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12:1475–81. <https://doi.org/10.1161/01.ATV.12.12.1475>
30. Šimák J, Holada K, Janota J et al. Surface expression of major membrane glycoproteins on resting and TRAP- activated neonatal platelets. Ped Res 1999; 46(4):445–49. <https://doi.org/10.1203/00006450-199910000-00014>
31. Wahba A, Rothe G, Lodes H et al. Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens folowing heart surgery. Thromb Res 2000; 97:379–86. <https://doi.org/10.1016/S0049-3848(99)00181-4>
32. Zdebska E, Wozniak, J, Dzieciatkowska A et al. In comparison to progenitor platelets, microparticles are deficient in GP Ib, GP Ib-derived carbohydrates, glycerophospholipids, glycosphingolipids, and ceramides. Acta Biochim Pol 1998; 45(2):417–28.
33. Zhao L, Bath P, Heptinstall S. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol 2001; 134(2):353–8. <https://doi.org/10.1038/sj.bjp.0704248> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive